Skip to main content
Home
Center for Technology Transfer & Commercialization
  • Home
  • About
  • Inventors
  • Industry
  • Startup Support
  • News & Events
  • Contact Us
  • Quick Links

Search form

Chikungunya
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • YouTube icon

Displaying 1 - 3 of 3


Chikungunya antibody identified at VUMC moves forward

Chikungunya antibody identified at VUMC moves forward


  • Read more about Chikungunya antibody identified at VUMC moves forward
Related Categories: 
antibodies Chikungunya virus James Crowe Jr. Research Vanderbilt Vaccine Center

VUMC Licensee Evotec Starts Clinical Development of Chikungunya Antibody

VUMC Licensee Evotec Starts Clinical Development of Chikungunya Antibody


  • Read more about VUMC Licensee Evotec Starts Clinical Development of Chikungunya Antibody
Related Categories: 
Press release Evotec Evotec SE Chikungunya Vanderbilt Vaccine Center James E. Crowe Jim Crowe EVT894 chikungunya virus monoclonal antibody antibody therapies

VUMC joins national effort to block global pandemics of potentially lethal viruses

The U.S. Defense Advanced Research Projects Agency (DARPA) has signed a five-year cooperative agreement worth up to $28 million with Vanderbilt University Medical Center (VUMC) to develop methods for preventing the global spread of viruses like chikungunya and Zika.


  • Read more about VUMC joins national effort to block global pandemics of potentially lethal viruses
Related Categories: 
DARPA U.S. Defense Advanced Research Projects Agency Vanderbilt University Medical Center VUMC Vanderbilt Vaccine Center ZIKA Chikungunya
Center for Technology Transfer & Commercialization
2100 West End Ave, Suite 750
Nashville, TN 37203
Tel: 615.343.2430
 
© 2014 -2025 Vanderbilt University
Send message